Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

KRAS G12C inhibitor 45

SKU: orb1744966

Description

Compound 45 is a potent and selective small molecule inhibitor targeting the KRAS G12C mutation. It is a valuable research tool for investigating oncogenic KRAS signaling in both cellular and animal models of cancer, supporting preclinical studies in oncology and targeted therapy development.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number2670380-74-0
MW637.7
FormulaC32H33F2N5O5S
SMILESO=C1N(C=2C(C(=N1)N3[C@@H](C)CN(C(C=C)=O)[C@H](C)C3)=CC(F)=C(N2)C4=C(F)C=CC=C4O)C5=C(S(C)(=O)=O)C=CC=C5C(C)C
TargetRas,Others,Kras

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • KRAS G12C inhibitor 18 [orb1690701]

    2649788-45-2

    510.97

    C25H20ClFN4O3S

    5 mg
  • Divarasib [orb1737448]

    99.96% (May vary between batches)

    2417987-45-0

    622.06

    C29H32ClF4N7O2

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information